Jiangsu Hengrui Pharmaceuticals Co. Ltd. (JHPCY)
OTC
Real-time Data
01:30 PM
Day's Range
20.0052 wk Range
13.60Overview - JHPCY - Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Key Statistics
Valuation
Enterprise Value
25.49B
P/E (Trailing)
‪58.82‬
Price / Sales (TTM)
‪2.09‬
Price / Book
‪7.11‬
EV / EBITDA
‪2.68‬
Profitability
Gross Margin
‪86.59%‬
Profit Margin
‪86.20%‬
Operating Margin
‪27.57%‬
Return on Assets
‪11.03%‬
Return on Equity
‪12.47%‬
Ownership
Shares Outstanding
6.63B
Price stats
50-Day Avg
‪14.21‬
200-Day Avg
‪15.26‬
Dividends
Payout Ratio
‪17.16%‬
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - JHPCY - Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Peers - JHPCY - Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
- JHPCYOTCJiangsu Hengrui Pharmaceuticals Co. Ltd.66.37BMarket Cap+15.20%52-week change58.82P/E (Trailing)‪86.20%‬Profit Margin
- MKGAFOTCMerck KGaA70.96BMarket Cap+22.06%52-week change23.97P/E (Trailing)‪11.21%‬Profit Margin
- MKKGYOTCMerck KGaA Sponsored ADR70.08BMarket Cap+20.60%52-week change23.88P/E (Trailing)‪11.21%‬Profit Margin
- GALDYOTCGalderma Group AG Unsponsored ADR49.85BMarket Cap+20.44%52-week change58.64P/E (Trailing)‪14.57%‬Profit Margin
- GDERFOTCGalderma Group AG47.80BMarket Cap+25.78%52-week change66.16P/E (Trailing)‪14.57%‬Profit Margin
- HLNCFOTCHaleon plc42.44BMarket Cap-1.14%52-week change19.24P/E (Trailing)‪14.55%‬Profit Margin
- SDZNYOTCSandoz Group AG ADR39.86BMarket Cap+31.94%52-week change62.22P/E (Trailing)‪5.53%‬Profit Margin
Profile Summary - JHPCY - Jiangsu Hengrui Pharmaceuticals Co. Ltd.
About
Jiangsu Hengrui Pharmaceuticals Co. Ltd. is a leading biopharmaceutical company engaged in the research, development, manufacture, and commercialization of innovative drugs primarily in China and internationally. It specializes in antineoplastic agents for cancer treatment, surgical anesthesia drugs, infusion…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
